These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 16002057

  • 1. Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats.
    Yoshida J, Yamamoto K, Mano T, Sakata Y, Nishio M, Ohtani T, Hori M, Miwa T, Masuyama T.
    Cardiovasc Res; 2005 Oct 01; 68(1):118-27. PubMed ID: 16002057
    [Abstract] [Full Text] [Related]

  • 2. Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF).
    Miyata M, Sasaki T, Ikeda Y, Shinsato T, Kubozono T, Furusho Y, Kusumoto A, Hamasaki S, Tei C, COLD-CHF Investigators.
    J Cardiol; 2012 May 01; 59(3):352-8. PubMed ID: 22365947
    [Abstract] [Full Text] [Related]

  • 3. Comparative analysis of the therapeutic effects of long-acting and short-acting loop diuretics in the treatment of chronic heart failure using (123)I-metaiodobenzylguanidine scintigraphy.
    Hisatake S, Nanjo S, Fujimoto S, Yamashina S, Yuzawa H, Namiki A, Nakano H, Yamazaki J.
    Eur J Heart Fail; 2011 Aug 01; 13(8):892-8. PubMed ID: 21602550
    [Abstract] [Full Text] [Related]

  • 4. Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis.
    Fukui M, Tsujino T, Hirotani S, Ito H, Yamamoto K, Akasaka T, Hirano Y, Ohte N, Daimon T, Nakatani S, Kawabata M, Masuyama T.
    Heart Vessels; 2017 Jul 01; 32(7):865-871. PubMed ID: 28105515
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.
    Nishio M, Sakata Y, Mano T, Yoshida J, Ohtani T, Takeda Y, Miwa T, Masuyama T, Yamamoto K, Hori M.
    J Hypertens; 2007 Feb 01; 25(2):455-61. PubMed ID: 17211254
    [Abstract] [Full Text] [Related]

  • 6. Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure.
    Ichihara S, Noda A, Nagata K, Obata K, Xu J, Ichihara G, Oikawa S, Kawanishi S, Yamada Y, Yokota M.
    Cardiovasc Res; 2006 Feb 15; 69(3):726-35. PubMed ID: 16165109
    [Abstract] [Full Text] [Related]

  • 7. Patients With CONgestive Heart Failure Benefit From Long-Term Treatment Effects With Novel Treatment Using Azosemide Compared With Furosemide Derived From Existing Retrospective Study Data: CONTENTED.
    Toyoda S, Arikawa T, Inami S, Nishikawa R, Saito F, Watanabe R, Sakuma M, Kanaya T, Abe S, Inoue T.
    J Cardiovasc Pharmacol; 2019 Jun 15; 73(6):365-372. PubMed ID: 31162245
    [Abstract] [Full Text] [Related]

  • 8. Nicorandil but not ISDN upregulates endothelial nitric oxide synthase expression, preventing left ventricular remodeling and degradation of cardiac function in Dahl salt-sensitive hypertensive rats with congestive heart failure.
    Horinaka S, Kobayashi N, Yagi H, Mori Y, Matsuoka H.
    J Cardiovasc Pharmacol; 2006 May 15; 47(5):629-35. PubMed ID: 16775500
    [Abstract] [Full Text] [Related]

  • 9. Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure.
    Tomiyama H, Nakayama T, Watanabe G, Shiojima K, Sakuma Y, Yamamoto A, Imai Y, Yoshida H, Doba N.
    Am Heart J; 1999 Mar 15; 137(3):543-8. PubMed ID: 10047639
    [Abstract] [Full Text] [Related]

  • 10. Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure.
    Masuyama T, Tsujino T, Origasa H, Yamamoto K, Akasaka T, Hirano Y, Ohte N, Daimon T, Nakatani S, Ito H.
    Circ J; 2012 Mar 15; 76(4):833-42. PubMed ID: 22451450
    [Abstract] [Full Text] [Related]

  • 11. Effects of calcium sensitizer OR-1986 on a cardiovascular mortality and myocardial remodelling in hypertensive Dahl/Rapp rats.
    Louhelainen M, Merasto S, Finckenberg P, Vahtola E, Kaheinen P, Leskinen H, Levijoki J, Pollesello P, Haikala H, Mervaala EM.
    J Physiol Pharmacol; 2009 Sep 15; 60(3):41-7. PubMed ID: 19826180
    [Abstract] [Full Text] [Related]

  • 12. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
    Veeraveedu PT, Watanabe K, Ma M, Palaniyandi SS, Yamaguchi K, Kodama M, Aizawa Y.
    Biochem Pharmacol; 2008 Mar 15; 75(6):1322-30. PubMed ID: 18179782
    [Abstract] [Full Text] [Related]

  • 13. Pitavastatin improves cardiac function and survival in association with suppression of the myocardial endothelin system in a rat model of hypertensive heart failure.
    Saka M, Obata K, Ichihara S, Cheng XW, Kimata H, Nishizawa T, Noda A, Izawa H, Nagata K, Murohara T, Yokota M.
    J Cardiovasc Pharmacol; 2006 Jun 15; 47(6):770-9. PubMed ID: 16810078
    [Abstract] [Full Text] [Related]

  • 14. Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure.
    Goldsmith SR, Gilbertson DT, Mackedanz SA, Swan SK.
    J Card Fail; 2011 Dec 15; 17(12):982-9. PubMed ID: 22123359
    [Abstract] [Full Text] [Related]

  • 15. Basic fibroblast growth factor inhibits ventricular remodeling in Dahl salt-sensitive hypertensive rats.
    Suzuki T, Akasaka Y, Namiki A, Ito K, Ishikawa Y, Yamazaki J, Ishii T.
    J Hypertens; 2008 Dec 15; 26(12):2436-44. PubMed ID: 19008723
    [Abstract] [Full Text] [Related]

  • 16. Comparative effects of long and short-acting loop diuretics on mortality in patients with chronic heart failure.
    Kasama S, Toyama T, Kurabayashi M.
    Int J Cardiol; 2017 Oct 01; 244():242-244. PubMed ID: 28645802
    [Abstract] [Full Text] [Related]

  • 17. Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure.
    Tsutsui T, Tsutamoto T, Maeda K, Kinoshita M.
    J Cardiovasc Pharmacol; 2001 Oct 01; 38 Suppl 1():S81-5. PubMed ID: 11811366
    [Abstract] [Full Text] [Related]

  • 18. Relationship between cardiomyocyte cell death and cardiac function during hypertensive cardiac remodelling in Dahl rats.
    Ikeda S, Hamada M, Qu P, Hiasa G, Hashida H, Shigematsu Y, Hiwada K.
    Clin Sci (Lond); 2002 Mar 01; 102(3):329-35. PubMed ID: 11869174
    [Abstract] [Full Text] [Related]

  • 19. A comprehensive review of the loop diuretics: should furosemide be first line?
    Wargo KA, Banta WM.
    Ann Pharmacother; 2009 Nov 01; 43(11):1836-47. PubMed ID: 19843838
    [Abstract] [Full Text] [Related]

  • 20. Beneficial effects of torasemide on systolic wall stress and sympathetic nervous activity in asymptomatic or mildly symptomatic patients with heart failure: comparison with azosemide.
    Harada K, Izawa H, Nishizawa T, Hirashiki A, Murase Y, Kobayashi M, Isobe S, Cheng XW, Noda A, Nagata K, Yokota M, Murohara T.
    J Cardiovasc Pharmacol; 2009 Jun 01; 53(6):468-73. PubMed ID: 19430310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.